# Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma

> **NCT00290667** · PHASE2 · COMPLETED · sponsor: **German High-Grade Non-Hodgkin's Lymphoma Study Group** · enrollment: 586 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** pegfilgrastim
- **BIOLOGICAL:** rituximab
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** prednisone
- **DRUG:** vincristine sulfate
- **OTHER:** pharmacological study
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00290667
- **Lead sponsor:** German High-Grade Non-Hodgkin's Lymphoma Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2013-12
- **Final completion:** 2015-11
- **Target enrollment:** 586 (ACTUAL)
- **Last updated:** 2021-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00290667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00290667, "Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00290667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*